Showing results (71-80 of 173) with videos related to
Sort By:
Pageof 18
Diabetes Research and Clinical Practice|May 22, 2023
Higher incidence of cardiovascular-kidney complications in Chinese with youth-onset type 2 diabetes versus youth-onset type 1 diabetes attenuated by control of cardio-metabolic risk factors: A population-based prospective cohort study in Hong KongYingnan Fan, Eric S H Lau, Hongjiang Wu, et al.Diabetes/Metabolism Research and Reviews|September 28, 2018
Interactive effects of testosterone and the androgen receptor CAG repeat length polymorphism on cardiovascular-renal events and mortality in men with diabetesPoon-Wing Wong, Heung-Man Lee, Eric S H Lau, et al.The Lancet Regional Health. Western Pacific|June 7, 2023
Incident cardiovascular-kidney disease, diabetic ketoacidosis, hypoglycaemia and mortality in adult-onset type 1 diabetes: a population-based retrospective cohort study in Hong KongYingnan Fan, Eric S H Lau, Hongjiang Wu, et al.Cardiovascular Diabetology|May 14, 2020
Trends in diabetes-related complications in Hong Kong, 2001-2016: a retrospective cohort studyHongjiang Wu, Eric S H Lau, Aimin Yang, et al.Diabetes Care|October 13, 2020
Trends in Glucose-Lowering Drug Use, Glycemic Control, and Severe Hypoglycemia in Adults With Diabetes in Hong Kong, 2002-2016Aimin Yang, Hongjiang Wu, Eric S H Lau, et al.Journal of Medical Virology|December 19, 2001
Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitisJ Z Zhang, Stanley W K Im, S H Lau, et al.Diabetes Care|December 21, 2013
Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetesAndrea O Y Luk, Eric S H Lau, Wing-Yee So, et al.Diabetologia|September 24, 2020
Secular trends in rates of hospitalisation for lower extremity amputation and 1 year mortality in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort studyHongjiang Wu, Aimin Yang, Eric S H Lau, et al.Ebiomedicine|August 15, 2022
Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019)Aimin Yang, Hongjiang Wu, Eric S H Lau, et al.Diabetes/Metabolism Research and Reviews|August 27, 2023
Early treatment with dipeptidyl-peptidase 4 inhibitors reduces glycaemic variability and delays insulin initiation in type 2 diabetes: A propensity score-matched cohort studyJohnny T K Cheung, Aimin Yang, Hongjiang Wu, et al.Pageof 18